Local News: Fayetteville, AR 

 | 

Sign Up

 | 

Sign In

GlaxoSmithKline

Forum & Polls

News

6 hrs ago | Vancouver Sun

Analysts at odds over health of flu-challenged Internet

A handout file photo shows a technician holding a master H1N1 virus sample, for the pre-production of a vaccine against pandemic influenza A virus at a laboratory of GlaxoSmithKline in Dresden June 16, 2009.

Comment?

Related Topix: H1N1 Influenza / Swine Flu, Health, Epidemic, Natural Disasters, Medicine, Influenza, Biotech, Healthcare Industry

Sat Nov 21, 2009

680News

Officials investigating one lot of flu vaccine due to allergy concerns

Lambert, Steve - The provinces are being asked to hold back a batch of swine flu vaccine that appears to be causing higher rates of severe allergic reactions.

Comment?

Related Topix: Medicine, Influenza, Health, North America, Canada, World News, H1N1 Influenza / Swine Flu, Biotech

Fri Nov 20, 2009

National Post

GlaxoSmithKline shelves lot of H1N1 vaccine

Canada's H1N1 flu vaccine manufacturer has asked the provinces to temporarily discontinue vaccinating Canadians from a lot of vaccine shipped in October due to a higher risk of adverse reactions, says a Manitoba health official.

Comment?

Related Topix: Biotech, H1N1 Influenza / Swine Flu, Medicine, Health, Healthcare Industry, Influenza

Thu Nov 19, 2009

Medical News

Anacor Pharmaceuticals commences patient dosing in AN3365 Phase I clinical study

Anacor Pharmaceuticals today announced that it has dosed the first patient in a Phase I clinical study for AN3365, a novel boron-based, small-molecule drug candidate in development for the treatment of hospital infections caused by Gram-negative bacteria.

Comment?

Related Topix: E. Coli, Health, Biotech, Medicine, Healthcare Industry, Chemistry, Science

Wed Nov 18, 2009

MediLexicon

Vaccine To Treat Nicotine Addiction Steps Closer To Market As Companies Agree Option Deal

Main Category: Smoking / Quit Smoking Also Included In: Pharma Industry / Biotech Industry An experimental vaccine called NicVAX, designed to treat nicotine addiction that works by stopping the drug from reaching the brain, moved a step closer to the market when the vaccine developer Nabi Biopharmaceuticals , based in Rockville, Maryland, US agreed ...

Comment?

Related Topix: Nicotine, NicoDerm, Nicotine (generic), Medicine, Medication, Smoking, Health, Biotech, Nabi Biopharmaceuticals, Healthcare Industry, Rockville, MD, World News, Belgium

AndhraNews

Soon, an injectable vaccine to help kick the butt

ANI ANI Soon, an injectable vaccine to help kick the butt Good news for smokers struggling to quit: an injectable vaccine has been developed that may help them kick the habit.

Comment?

Related Topix: Smoking, Medicine, Health, Biotech, Nicotine, NicoDerm, Nicotine (generic), Medication

Tue Nov 17, 2009

Nashua Telegraph

Vaccines for AIDS, herpes, Alzheimer's could hit market within 5 years

In this undated photo provided by Sanofi Pasteur, technicians perform production operations during a dry run at the company's influenza manufacturing facility in Swiftwater, Pa.

Comment?

Related Topix: Swiftwater, PA, Maple Glen, PA, Biotech, Medicine, Healthcare Industry, Marietta, PA, Epidemic, Natural Disasters

Fox News

Lazard Taps Jacobs to Succeed Wasserstein

Investment bank Lazard Tuesday named Kenneth Jacobs, 51, its new chairman and chief executive, replacing Bruce Wasserstein, who unexpectedly died last month.

Comment?

Related Topix: Investment Banking, Financial Services, Biotech, Business News

Mon Nov 16, 2009

Legal Times

GlaxoSmithKline Scores a Big Win in Drug Pricing Fraud Trial

Has the tide turned against states in their drug pricing suits against Big Pharma? Last month, we reported on a landmark ruling from the Alabama Supreme Court that threw out more than $270 million in verdicts against Novartis, GlaxoSmithKline and AstraZeneca, which had been found liable for overcharging the state Medicaid system for drugs.

Comment?

Related Topix: Healthcare Law, Law, Biotech, Medicine, AstraZeneca Group, Healthcare Industry

Fox News

Nabi, Glaxo Agree Nicotine Vaccine Licensing Deal

Nabi Biopharmaceuticals and a division of GlaxoSmithKline said Monday they have entered an option and licensing agreement over an investigational vaccine for the treatment of nicotine addiction.

Comment?

Related Topix: Biotech, Medicine, Nabi Biopharmaceuticals, Healthcare Industry, Business News

Sun Nov 15, 2009

Medical News Today

GSK To Donate 50M H1N1 Vaccine Doses To WHO In Coming Months

Main Category: Swine Flu Also Included In: Immune System / Vaccines ; Aid / Disasters Article Date: 11 Nov 2009 - 4:00 PST Drugmaker GlaxoSmithKline announced plans on Tuesday to donate 50 million doses of its H1N1 vaccine to the WHO for use in developing countries within the next few months, Reuters reports.

Comment?

Related Topix: H1N1 Influenza / Swine Flu, Health, Biotech

The Motley Fool

The Life-and-Death Situation That Isn't

"This is literally a life-and-death issue that must be handled with great care." -- Celgene spokesman Brian Gill, as quoted in The Wall Street Journal .

Comment?

Related Topix: Biotech, Celgene, Medicine, Healthcare Industry, Teva Pharmaceutical Industries, Pharmaceuticals, Mylan Laboratories, Novartis, Thalomid, Thalidomide (generic), Medication

Sat Nov 14, 2009

Rehab Management

Severe asthma attacks in kids averted by fluticasone/salmeterol combo

In asthmatic children, treatment with fluticasone plus salmeterol is associated with fewer serious exacerbations and lower medical costs compared to the use of an inhaled corticosteroid plus montelukast.

Comment?

Related Topix: Medicine, Asthma, Health, Advair Diskus, Fluticasone/Salmeterol (generic), Medication, Family, Kids, Fluticasone (generic), Flovent, Singulair, Montelukast (generic), Biotech

Health Care Renewal

Suppression of Clinical Trials of Sumatriptan

Correspondence to the Lancet two weeks ago revealed another instance in which clinical research studies that failed to provide results favorable to a sponsor's product were suppressed.

Comment?

Related Topix: Medicine, Imitrex, Sumatriptan (generic), Medication, Biotech, Healthcare Industry, Migraine Headache, Health, Headache, Migraine

Canadian Online Health News

Health Canada approves adjuvant-free H1N1 vaccine but not for small children

Clinics and doctors across the country were given the green light Friday to start using 1.8 million doses of H1N1 vaccine made without adjuvant - but they were told not to give it to one of the originally intended recipient groups.

Comment?

Related Topix: H1N1 Influenza / Swine Flu, Health, Biotech, Medicine, Influenza

Fri Nov 13, 2009

Nurse.com

Special Coverage: H1N1 Influenza News

Nov. 11 Federal Food and Drug Administration Commissioner Margaret Hamburg, M.D., has posted an open letter praising doctors, nurses, and other health professionals for their 'extraordinary efforts' in responding to the 2009 H1N1 influenza outbreak, for which 41 million doses of vaccine has been allocated to the states with more becoming available ...

Comment?

Related Topix: H1N1 Influenza / Swine Flu, Health, Medicine, Influenza, Food and Drug Administration, Nursing, Epidemic, Natural Disasters, Biotech

BioSpace

Astex Therapeutics Announces $33 Million Strategic Drug Discovery Alliance with GlaxoSmithKline

Cambridge, UK, 12th November 2009. Astex Therapeutics Limited announced today that it has entered into a new collaboration agreement with GlaxoSmithKline to discover, develop and commercialise novel compounds directed against multiple therapeutic targets of interest to GSK.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Ottawa Citizen

Canada's top doctor says no delay in flu vaccine

Canada is not moving too slowly on the production and approval of the H1N1 flu vaccine, the countrya TMs chief public health officer said Tuesday.

Comment?

Related Topix: North America, Canada, World News, Medicine, Influenza, Health, H1N1 Influenza / Swine Flu, Biotech, Healthcare Industry,

Thu Nov 12, 2009

BreakingNews.ie

Stiefel Laboratories workers absorb news of plant closure

Two hundred and fifty workers in Sligo are today coming to terms with the news that their jobs are gone, with the closure of Stiefel Laboratories.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

The State

Drug industry presses FDA to allow more online ads

As federal regulators take their first tentative steps toward policing the wild west of medical information online, pharmaceutical companies are pressing their case to market drugs via Google, Twitter and other Web sites.

Comment?

Related Topix: Food and Drug Administration, Emerging Technology, Search Engines, Marketing, Internet, Science / Technology, Pfizer, Biotech, Medicine, Healthcare Industry

Fayetteville Jobs

Also on Topix